Skip to main content

Developing iPSC Cells as Therapeutics

25 Jun 2024
Salon A
iPSCs Technology
  • Clinical grade iPSC line generation: which method is the ideal one ?
  • As fully differentiated cells are the final products, what is the best approach to efficiently eliminate undifferentiated iPSC cells and to avoid tumorigenic potential?
  • CMC and Scale: is industrial scale-up necessary for iPSC-derived cell products? If Yes, what is the best approach?
Industry Expert
John Lu, President and CEO - HebeCell Corporation